HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
A phase 2b, multicenter, randomized, double-blind, placebo-controlled study of HTD1801 in adult subjects with non-alcoholic steatohepatitis and liver fibrosis who have type 2 diabetes mellitus or pre-diabetes.
Epistemonikos ID: 48448e49ad2d8696f43b93a3f52fbf622dd83cb3
First added on: Sep 12, 2023